Research progress of transcranial alternating current stimulation in the treatment of cognitive impairment in neuropsychiatric diseases
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2024, Vol 50, Issue 1
Abstract
Cognitive dysfunction is the impairment of higher brain functions. Cognitive impairment caused by neuropsychiatric diseases has caused serious impact on patients' quality of life and the outcome of the disease. The transcranial alternating current stimulation (tACS) improves cognitive function by modulating neural oscillations of specific frequencies, affecting the release of neurotransmitters such as serotonin and dopamine, and enhancing local and distal synchronization of brain networks. Specific frequencies of tACS can improve the cognitive impairment caused by Alzheimer disease (AD), schizophrenia, and depression, among which the gamma and theta frequencies of tACS have the most significant effects on cognitive function. tACS has high safety and low operational difficulty, and has great potential to improve cognitive function.
Authors and Affiliations
Xuelin ZHANG, Qiuli YANG, Xiaying SI, Peishan HUANG, Ke WANG, Yi MIAO, Qiangli DONG
Keywords
Related Articles
- EP ID EP750402
- DOI 10.3969/j.issn.1002-0152.2024.01.008
- Views 27
- Downloads 0
Different types of cerebral infarction caused by severe mycoplasma pneumoniae pneumonia in 3 children
To summarize the clinical features and treatment outcomes of 3 children with lacunar cerebral infarction, middle inferior cerebral trunk infarction and watershed cerebral infarction caused by severe mycoplasma pneumoniae...
Case report of primary coenzyme Q10 deficiency caused by COQ8A gene mutation
Primary coenzyme Q10 deficiency is an autosomal recessive disorder caused by mutations in the genes encoding key enzymes in the biosynthesis of CoQ10. This paper reports for the first time a primary CoQ10 deficiency caus...
a case of paraneoplastic cerebellar ataxia syndrome associated with immunocheckpoint inhibitor treated with Ofatumumab
A case of paraneoplastic cerebellar ataxia syndrome caused by immune checkpoint inhibitors (ICI) was treated with ofatumumab (OFA). The patient is a 57-year-old male. He used “Camrelizumab” immunotherapy for his previous...
Chinese experts consensus on chemotherapy for glioma
Glioma is the most prevalent primary intracranial malignant tumor. At present, the main therapy is surgical resection, supplemented by radiotherapy and chemotherapy. Clinical practice has demonstrated that chemotherapy i...
Research progress on the mechanism and treatment of zinc finger protein A20 in psychiatric diseases
The clinical efficacy of mental illness is not good. Therefore, it is particularly important to find new therapeutic targets and new drugs. At present, it has been found that neuroimmune response is closely related to ps...